ÂÜÀòÂÒÂ×

Yi Ching Yau has extensive experience in finance and accounting, starting as an Audit Senior Manager at Ernst & Young LLP in 2000. Yi Ching then moved on to roles such as Corporate Controller at Theravance Biopharma, VP Finance at Nektar Therapeutics, Chief Accounting Officer at BridgeBio, SVP Finance and Principal Accounting Officer at ChemoCentryx, and currently holds the position of Senior Vice President Finance and Accounting at Lassen Therapeutics. Yi Ching'scareer progression demonstrates a strong background in financial management and leadership.

Yi Ching Yau obtained a Bachelor of Accountancy from Nanyang Technological University Singapore from 1996 to 1999.